These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 2423708)
1. Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation. Loehrer PJ; Hui S; Clark S; Seal M; Einhorn LH; Williams SD; Ulbright T; Mandelbaum I; Rowland R; Donohue JP J Urol; 1986 Jun; 135(6):1183-9. PubMed ID: 2423708 [TBL] [Abstract][Full Text] [Related]
2. Resection of thoracic and abdominal teratoma in patients after cisplatin-based chemotherapy for germ cell tumor. Late results. Loehrer PJ; Mandelbaum I; Hui S; Clark S; Einhorn LH; Williams SD; Donohue JP J Thorac Cardiovasc Surg; 1986 Oct; 92(4):676-83. PubMed ID: 3020319 [TBL] [Abstract][Full Text] [Related]
3. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer. Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728 [TBL] [Abstract][Full Text] [Related]
4. Multiple relapses of mature teratoma, germinal and non-germ cell cancer in a patient treated with chemotherapy for testicular non-seminomatous germ cell cancer. McKendrick JJ; Mead GM; Cowlishaw D Clin Oncol (R Coll Radiol); 2003 May; 15(3):128-31. PubMed ID: 12801050 [No Abstract] [Full Text] [Related]
5. Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors. Kundu SD; Feldman DR; Carver BS; Gupta A; Bosl GJ; Motzer RJ; Bajorin DF; Sheinfeld J J Urol; 2015 Feb; 193(2):513-8. PubMed ID: 25150639 [TBL] [Abstract][Full Text] [Related]
6. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis. Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213 [TBL] [Abstract][Full Text] [Related]
7. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience. Srougi M; Simon SD; de Góes GM J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300 [TBL] [Abstract][Full Text] [Related]
8. Reassessment of the role of adjunctive surgical therapy in the treatment of advanced germ cell tumors. Carter GE; Lieskovsky G; Skinner DG; Daniels JR J Urol; 1987 Dec; 138(6):1397-401. PubMed ID: 2446018 [TBL] [Abstract][Full Text] [Related]
9. Cancer of the testis: a new paradigm. Einhorn LH Hosp Pract (Off Ed); 1986 Apr; 21(4):165-72, 175-8. PubMed ID: 2420812 [No Abstract] [Full Text] [Related]
10. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis. Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800 [TBL] [Abstract][Full Text] [Related]
12. Survival after an antiangiogenetic therapy and surgery in a wide spread growing teratoma originating from a testicular mixed malignant germ cell tumor. Calaminus G; Schneider DT; Weissbach L; Schönberger S; Okpanyi V; Leuschner I; Poremba C; Göbel U Klin Padiatr; 2009; 221(3):136-40. PubMed ID: 19437360 [TBL] [Abstract][Full Text] [Related]
13. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer. Fosså SD; Aass N; Ous S; Høie J; Stenwig AE; Lien HH; Paus E; Kaalhus O J Urol; 1989 Nov; 142(5):1239-42. PubMed ID: 2478726 [TBL] [Abstract][Full Text] [Related]
14. Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin-vinblastine-bleomycin chemotherapy. Gelderman WA; Schraffordt Koops H; Sleijfer DT; Oosterhuis JW; Van der Heide JN; Mulder NH; Marrink J; De Bruyn HW; Oldhoff J J Surg Oncol; 1988 Aug; 38(4):227-32. PubMed ID: 2457771 [TBL] [Abstract][Full Text] [Related]
15. Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancer. Pizzocaro G; Piva L; Salvioni R; Zanoni F; Milani A Cancer; 1985 Nov; 56(10):2411-5. PubMed ID: 2412683 [TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy including VP-16 for poor prognosis germ cell neoplasms. Bukowski RM; Smith GW; Montie JE Urology; 1988 May; 31(5):403-7. PubMed ID: 2452507 [TBL] [Abstract][Full Text] [Related]
17. Late recurrence of mature teratoma in nonseminomatous testicular tumors after PVB chemotherapy and surgery. Gelderman WA; Scraffordt Koops H; Sleijfer DT; Oosterhuis JW; Oldhoff J Urology; 1989 Jan; 33(1):10-4. PubMed ID: 2463704 [TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of patients with stages I and II nonseminomatous testicular cancer. Fraley EE; Narayan P; Vogelzang NJ; Kennedy BJ; Lange PH J Urol; 1985 Jul; 134(1):70-3. PubMed ID: 2409301 [TBL] [Abstract][Full Text] [Related]
19. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors. Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858 [TBL] [Abstract][Full Text] [Related]
20. Postchemotherapy surgery in nonseminomatous testicular tumors. Hornák M; Ondrus D; Matoska J; Cársky S Eur Urol; 1996; 29(3):325-30. PubMed ID: 8740018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]